URSOFALK

This brand name is authorized in Austria, Australia, Cyprus, Germany, Ecuador, Estonia, Hong Kong, Croatia, Ireland, Israel, Lithuania, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom, South Africa

Active ingredients

The drug URSOFALK contains one active pharmaceutical ingredient (API):

1 Ursodeoxycholic acid
UNII 724L30Y2QR - URSODIOL

The ursodeoxycholic acid converts lithogenic bile in non-lithogenic bile and gradually dissolves the cholesterol gallstones.

Read about Ursodeoxycholic acid

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
URSOFALK Capsule, hard Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
A05AA02 Ursodeoxycholic acid A Alimentary tract and metabolism → A05 Bile and liver therapy → A05A Bile therapy → A05AA Bile acid preparations
Discover more medicines within A05AA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 11180K, 8448P
Country: DE Bundesinstitut für Arzneimittel und Medizinprodukte Identifier(s): 02144453, 02144536, 02244781, 02244798, 05969102, 05985265, 06972218, 06972224, 10972974, 10972980, 16166961, 16166978
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 22.754-1-07-06
Country: EE Ravimiamet Identifier(s): 1044818, 1063101
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 139646, 175982, 196215, 200298, 200299, 217141, 28592, 28710, 373938, 377079, 381723, 56519
Country: HK Department of Health Drug Office Identifier(s): 57786, 65379
Country: HR Agencija za lijekove i medicinske proizvode Identifier(s): HR-H-837713755
Country: IE Health Products Regulatory Authority Identifier(s): 32975, 48530, 48531, 48545, 48569, 68561, 68953
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 4884, 7766
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1002229, 1005473, 1036970, 1055167
Country: MX Comisión Federal para la Protección contra Riesgos Sanitarios Identifier(s): 222M89
Country: NL Z-Index G-Standaard, PRK Identifier(s): 105759, 106054, 15830
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 11194
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100069566, 100250366, 100250768
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W00187001, W00187002, W58363001, W58363002, W58710001, W58710002
Country: SG Health Sciences Authority Identifier(s): 05742P, 14545P
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8699543150031, 8699543700052
Country: ZA Health Products Regulatory Authority Identifier(s): 43/11.10/0442

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.